Ignite Creation Date:
2024-05-06 @ 1:38 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01857193
Status:
COMPLETED
Last Update Posted:
2021-04-13
First Post:
2013-05-16
Brief Title:
Phase Ib Trial of LEE011 With Everolimus RAD001 and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis